JNGHF — Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 2071868 ·
China
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Yahoo Snapshot (yfinance, live)
Total Revenue
$32,564,369,408
EBITDA
$9,452,852,224
Free Cash Flow
$6,307,738,624
Enterprise Value
$7,611,628,032
Total Cash
$40,635,797,504
Total Debt
$67,474,744
Shares Out
—
Trailing EPS
—
Book Value
$1.39
ROE
14.5%
ROA
8.8%
Div Yield
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRUST | $700.70B | $763.47 | — |
| QQQ | INVESCO QQQ TRUST, SERIES 1 | $277.65B | $706.32 | — |
| KLAC | KLA CORP | $237.23B | $181.57 | — |
| TMO | THERMO FISHER SCIENTIFIC INC. | $232.47B | $628.74 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $217.67B | $231.04 | — |
News headlines (Yahoo Finance, 1h cache)
Hengrui’s Heng Yi® Approved in China as an Innovative Cyclosporine Ophthalmic Solution for the Treatment of Dry Eye Disease
2026-06-30 05:00 · Yahoo
Hengrui Pharma Reports Steady Growth in Q3 2025 Driven by Innovation and Global Expansion
2025-10-27 11:34 · Yahoo
Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)
2025-09-24 11:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.